WOCKPHARMA — Wockhardt Share News
0.000.00%
- IN₹317.66bn
- IN₹337.11bn
- IN₹33.73bn
India's Wockhardt continues its upward rally, hits near 8-yr high
India's Wockhardt up 20% on antibiotic drug's success
Brief: Wockhardt Says Zaynich Successful Used To Treat Cancer Patient In U.S. With Chronic Bilateral Thigh Infection
Brief: Wockhardt Re-Appoints Habil Khorakiwala As Executive Chairman
Brief: Wockhardt To Consider Raising Of Funds
India's Wockhardt rises after launching share sale to institutional investors
Brief: Wockhardt Dec-Qtr Consol Net Loss Narrows
India's Wockhardt hits near 2-yr high after completion of pneumonia study
Brief: Wockhardt Says Completion Of Phase 3 Pneumonia Study Of Nafithromycin Wck 4873
India's Wockhardt rises most in nearly 3 yrs on multiple block deals
Brief: Wockhardt June-Qtr Consol Net Loss Widens
Guardian Finance To Reinstate Invoked Pledged Shares
Brief: Wockhardt Says Guardian Finance Has Wrongfully Invoked Pledge On 20,00,000 Shares Of Co
Media: India's Wockhardt to reduce debt against share pledge to 26% from 65% in FY24 - ET
Brief: Wockhardt Re-Appoints Murtaza Khorakiwala As MD
Brief: Wockhardt Gets SEBI Settlement Order On Show Cause Notice Dated Sept 15, 2022
Brief: Wockhardt To Consider Raising Of Funds
India's Wockhardt falls to 3-year low; stock signals bearish bias
India's Wockhardt jumps on restructuring plans